These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 239733)

  • 21. Pharmacology of dihydroxy-dibutylether, a specific choleretic drug.
    Fregnan GB; Porta R
    Arzneimittelforschung; 1976; 26(11):2116-24. PubMed ID: 1037259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of zolimidine (2-(p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine) a new non-anticholinergic gastroprotective agent. III). Gastric antisecretory activity, antagonism against acid hypersecretion induced by pentagastrin and histamine, and other effects.
    Murmann W; Carminati GM; Cattaneo R
    Panminerva Med; 1974 Oct; 16(10):335-46. PubMed ID: 4155796
    [No Abstract]   [Full Text] [Related]  

  • 24. Further studies on lidoflazine (R-7904).
    Türker RK; Kayaalp SO; Ozer A
    Arzneimittelforschung; 1968 Sep; 18(9):1209-12. PubMed ID: 4387885
    [No Abstract]   [Full Text] [Related]  

  • 25. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [General pharmacological studies on cis-1-acetyl-4-[4-[[2-(2, 4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl] methoxy] phenyl] piperazine].
    Nakamura J; Yamada K; Shuto K; Marumo H
    Jpn J Antibiot; 1982 Jun; 35(6):1629-48. PubMed ID: 6290709
    [No Abstract]   [Full Text] [Related]  

  • 27. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system.
    Cosnier D; Hache J; Labrid C; Rispat G
    Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General pharmacological properties of dapiprazole, a potential psychotropic agent.
    Lisciani R; Baldini A; Silvestrini B
    Arzneimittelforschung; 1982; 32(6):674-8. PubMed ID: 6126198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric antisecretory and antiulcer agents.
    Bass P
    Adv Drug Res; 1974; 8():205-334. PubMed ID: 4142832
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiulcerogenic effect of a pyrido-benzodiazepine derivative (L-S 519) on experimental ulcers.
    Kitagawa H; Kurahashi K; Fujiwara M; Kohei H
    Arzneimittelforschung; 1978; 28(11):2122-7. PubMed ID: 582916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [General pharmacological effects of flupentixol].
    Ueki S; Watanabe S; Morimot Y; Masuda M
    Igaku Kenkyu; 1971 Jul; 41(5):441-51. PubMed ID: 5165981
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacology of the new H1-receptor antagonist setastine hydrochloride.
    Porszász J; Varga F; Porszász KG; Szolscányi J; Barthó L; Petöcz L; Kápolnai L
    Arzneimittelforschung; 1990 Dec; 40(12):1340-5. PubMed ID: 1982751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part I. General pharmacological properties.
    Ernest K
    Pol J Pharmacol Pharm; 1975; 27(4):363-79. PubMed ID: 241067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisecretory activity of 6-aminoindazole in rats.
    Pinelli A; Trivulzio S; Malvezzi L; Rossoni G; Berti F
    Arzneimittelforschung; 1989 Mar; 39(3):361-5. PubMed ID: 2547388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Denzimol, a new anticonvulsant drug. II. General pharmacological activities.
    Graziani G; Cazzulani P; Luca C; Nava G; Testa R
    Arzneimittelforschung; 1983; 33(8):1161-8. PubMed ID: 6685494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The general pharmacology of a novel antitussive compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
    Boksay IJ; Popendiker K; Weber RO; Söder A
    Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
    Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
    [No Abstract]   [Full Text] [Related]  

  • 40. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.